Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 10
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.
| Dosage form | NDCs |
|---|---|
| injection, solution | 1 |
| tablet, effervescent | 1 |
| Route | NDCs |
|---|---|
| oral | 1 |
| subcutaneous | 1 |
| Labeller name on the listing | NDCs |
|---|---|
| radius health, inc. | 2 |
Exclusivity
Patents and exclusivities
10| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8748382 | TYMLOSabaloparatide | use | Oct 2027 |
| 8148333 | TYMLOSabaloparatide | product | Nov 2027 |
| 7803770 | TYMLOSabaloparatide | use | Apr 2031 |
| RE49444 | TYMLOSabaloparatide | use | Apr 2031 |
| 9592195 | BINOSTOalendronate sodium | product | Dec 2031 |
| 10996208 | TYMLOSabaloparatide | product | Apr 2038 |
| 11782041 | TYMLOSabaloparatide | product | Apr 2038 |
| 11977067 | TYMLOSabaloparatide | product | Apr 2038 |
| 11255842 | TYMLOSabaloparatide | use | Jan 2040 |
| 11680942 | TYMLOSabaloparatide | use | Jan 2040 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Binosto | alendronate sodium | tablet, effervescent, oral | 70539-400NDA |
| Tymlos | abaloparatide | injection, solution, subcutaneous | 70539-001NDA |
Enquiry
Common questions
- Is Radius Health, Inc. FDA approved?
- Radius Health, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Radius Health, Inc. make?
- 2 products are listed under Radius Health, Inc. in the openFDA NDC Directory, most often as injection, solution; tablet, effervescent. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.